{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:27:54Z","timestamp":1789165674239,"version":"build-2803163510"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1097\/md.0000000000009246","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T13:45:18Z","timestamp":1513172718000},"page":"e9246","source":"Crossref","is-referenced-by-count":3,"title":["Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility"],"prefix":"10.1097","volume":"96","author":[{"given":"Yafei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengdi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruofeng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-107-20210226","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R2-107-20210226","first-page":"609","article-title":"[Breast cancer: morbidity, mortality, survival (population study)]","volume":"57","author":"Merabishvili","year":"2011","journal-title":"Vopr Onkol"},{"key":"R3-107-20210226","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gde.2015.01.004","article-title":"From candidate gene studies to GWAS and post-GWAS analyses in breast cancer","volume":"30","author":"Fachal","year":"2015","journal-title":"Curr Opin Genet Dev"},{"key":"R4-107-20210226","first-page":"1058","article-title":"[Current status of genome-wide association studies (GWAS) on breast cancer and application values of single nucleotide polymorphisms identified from GWAS]","volume":"36","author":"Huang","year":"2015","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"R5-107-20210226","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10549-012-2359-z","article-title":"Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population","volume":"137","author":"Jara","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"R6-107-20210226","doi-asserted-by":"crossref","first-page":"626948","DOI":"10.1155\/2015\/626948","article-title":"Heterogeneity of breast cancer associations with common genetic variants in FGFR2 according to the intrinsic subtypes in Southern Han Chinese women","volume":"2015","author":"Liang","year":"2015","journal-title":"Biomed Res Int"},{"key":"R7-107-20210226","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4103\/0973-1482.114434","article-title":"An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer","volume":"9","author":"Ozgoz","year":"2013","journal-title":"J Cancer Res Ther"},{"key":"R8-107-20210226","doi-asserted-by":"crossref","first-page":"7955","DOI":"10.7314\/APJCP.2014.15.18.7955","article-title":"Association of rs1219648 in FGFR2 and rs1042522 in TP53 with premenopausal breast cancer in an Iranian Azeri population","volume":"15","author":"Saadatian","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R9-107-20210226","doi-asserted-by":"crossref","first-page":"e110426","DOI":"10.1371\/journal.pone.0110426","article-title":"A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India","volume":"9","author":"Siddiqui","year":"2014","journal-title":"PLoS One"},{"key":"R10-107-20210226","first-page":"1854","article-title":"FGFR2 gene polymorphisms are associated with breast cancer risk in the Han Chinese population","volume":"5","author":"Xia","year":"2015","journal-title":"Am J Cancer Res"},{"key":"R11-107-20210226","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/gme.0b013e318268ca46","article-title":"Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study","volume":"20","author":"Andersen","year":"2013","journal-title":"Menopause"},{"key":"R12-107-20210226","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10549-012-2234-y","article-title":"Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population","volume":"136","author":"Chan","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"R13-107-20210226","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10549-010-1032-7","article-title":"Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073\u200aC allele and FGFR2 rs1219648 G allele in North China","volume":"125","author":"Chen","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"R14-107-20210226","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/dna.2011.1351","article-title":"Crosstalk between the FGFR2 and TP53 genes in breast cancer: data from an association study and epistatic interaction analysis","volume":"31","author":"Cherdyntseva","year":"2012","journal-title":"DNA Cell Biol"},{"key":"R15-107-20210226","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1620\/tjem.226.221","article-title":"Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women","volume":"226","author":"Fu","year":"2012","journal-title":"Tohoku J Exp Med"},{"key":"R16-107-20210226","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ng2075","article-title":"A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer","volume":"39","author":"Hunter","year":"2007","journal-title":"Nat Genet"},{"key":"R17-107-20210226","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/ijc.24505","article-title":"FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan","volume":"125","author":"Kawase","year":"2009","journal-title":"Int J Cancer"},{"key":"R18-107-20210226","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1093\/carcin\/bgn235","article-title":"Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women","volume":"29","author":"Liang","year":"2008","journal-title":"Carcinogenesis"},{"key":"R19-107-20210226","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4048\/jbc.2013.16.4.366","article-title":"Case-control study on the fibroblast growth factor receptor 2 gene polymorphisms associated with breast cancer in Chinese Han women","volume":"16","author":"Liu","year":"2013","journal-title":"J Breast Cancer"},{"key":"R20-107-20210226","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2011-10-383380","article-title":"FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma","volume":"119","author":"Ma","year":"2012","journal-title":"Blood"},{"key":"R21-107-20210226","first-page":"413","article-title":"The relationship between two FGFR2 polymorphisms and breast cancer","volume":"36","author":"Mei","year":"2009","journal-title":"Chin J Clin Oncol"},{"key":"R22-107-20210226","first-page":"29","article-title":"The association of FGFR2 rs1219648 polymorphism with susceptibility of breast cancer in Han population in Guizhou province","volume":"37","author":"Mei","year":"2010","journal-title":"Chin J Clin Oncol"},{"key":"R23-107-20210226","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1158\/1055-9965.EPI-08-0018","article-title":"FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations","volume":"17","author":"Raskin","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R24-107-20210226","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10549-012-2202-6","article-title":"Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians","volume":"135","author":"Shan","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"R25-107-20210226","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10549-011-1498-y","article-title":"Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States","volume":"129","author":"Slattery","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"R26-107-20210226","first-page":"528","article-title":"Implication of the FGFR2 rs2981579 polymorphisms in breast cancer in Chinese han women","volume":"30","author":"Zhou","year":"2010","journal-title":"Suzhou Univ J Med Sci"},{"key":"R29-107-20210226","first-page":"111","article-title":"Relative research of FGFR2 gene single nucleotide polymorphism and breast neoplasm","volume":"14","author":"Ma","year":"2011","journal-title":"Chin J Curr Adv Gen Surg"},{"key":"R30-107-20210226","first-page":"43","article-title":"The relationship between rs2981579 FGFR2 gene polymorphism and breast cancer in Han and Tibetan women in Qinghai","volume":"30","author":"Zhao","year":"2012","journal-title":"Chin J Clin Lab Sci"},{"key":"R31-107-20210226","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s10549-012-2300-5","article-title":"Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis","volume":"136","author":"Zhou","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"R32-107-20210226","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10549-010-0846-7","article-title":"Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis","volume":"124","author":"Zhang","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"R33-107-20210226","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10549-012-2343-7","article-title":"Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk","volume":"137","author":"Wang","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"R34-107-20210226","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10549-011-1459-5","article-title":"Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies","volume":"127","author":"Peng","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"R35-107-20210226","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10549-010-0872-5","article-title":"Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer","volume":"124","author":"Jia","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"R36-107-20210226","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"R37-107-20210226","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R38-107-20210226","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"R39-107-20210226","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R40-107-20210226","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1074\/jbc.M601252200","article-title":"Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family","volume":"281","author":"Zhang","year":"2006","journal-title":"J Biol Chem"},{"key":"R41-107-20210226","first-page":"233","article-title":"Cancer genomics and genetics of FGFR2 (Review)","volume":"33","author":"Katoh","year":"2008","journal-title":"Int J Oncol"},{"key":"R42-107-20210226","first-page":"94","article-title":"Evaluation of FGFR2 gene polymorphism in women with breast cancer","volume":"61","author":"Salehi","year":"2015","journal-title":"Cell Mol Biol (Noisy-le-Grand, France"},{"key":"R43-107-20210226","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1309\/AJCPNFLSMWWPP8DR","article-title":"FGFR2 assessment in gastric cancer using quantitative real-time polymerase chain reaction, fluorescent in situ hybridization, and immunohistochemistry","volume":"143","author":"Park","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"R44-107-20210226","first-page":"3135","article-title":"Expression pattern of FGFR2, Grb2 and Plcgamma1 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinoma","volume":"5","author":"Timsah","year":"2015","journal-title":"Am J Cancer Res"},{"key":"R45-107-20210226","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4161\/cbt.10.5.12585","article-title":"Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer","volume":"10","author":"Cole","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"R46-107-20210226","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/modpathol.2011.110","article-title":"FGFR2 alterations in endometrial carcinoma","volume":"24","author":"Gatius","year":"2011","journal-title":"Mod Pathol"},{"key":"R47-107-20210226","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/bjc.1992.256","article-title":"Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues","volume":"66","author":"Luqmani","year":"1992","journal-title":"Br J Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000009246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:47:41Z","timestamp":1620960461000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201712150-00107"}},"subtitle":["A meta-analysis"],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":45,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000009246","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}